February 5, 2025 - 11:08

Tech stocks have been experiencing significant volatility, with Nvidia facing a notable 17% drop following concerns raised by DeepSeek, which unsettled investors. Despite this turmoil, many retail traders have chosen to buy the dip, adhering to a strategy that has gained traction since the onset of the pandemic. This behavior reflects a broader trend among retail investors who have increasingly engaged in stock market activities, often driven by a belief in the long-term potential of tech companies.
The inclination to purchase stocks during downturns has become a hallmark of retail trading, as many individuals view market dips as opportunities to invest at lower prices. This approach is reminiscent of the quantitative easing era, where easy monetary policies encouraged risk-taking and investment in growth sectors. As market fluctuations continue, retail traders remain undeterred, showcasing their resilience and commitment to capitalizing on perceived bargains in the tech sector. The ongoing participation of retail investors is shaping market dynamics, influencing both stock prices and investor sentiment.
May 17, 2026 - 08:31
How Investors Are Reacting To NVE (NVEC) Steady Earnings And Maintained Quarterly DividendNVE Corporation has released its full-year results for the period ending March 31, 2026, posting revenue of US$26.33 million and net income of US$15.2 million. The company also confirmed a...
May 16, 2026 - 22:25
Risky Integration or Rewarding Returns? The Stakes of SoundHound's LivePerson Acquisition.SoundHound AI`s acquisition of LivePerson is drawing mixed reactions from investors, with the immediate fallout hitting the stock price. The deal, which combines SoundHound`s voice AI technology...
May 16, 2026 - 10:38
Bank of Hawaii, Glacier Bancorp, and Wintrust Financial Shares Plummet, What You Need To KnowShares of several regional banks took a sharp hit in afternoon trading Wednesday after the latest inflation report came in hotter than expected. The April Consumer Price Index rose 3.8%, a figure...
May 15, 2026 - 17:39
Plus Therapeutics Shares First Quarter 2026 Financial Results and Updates on REYOBIQ and CNSide ProgressHOUSTON, May 15, 2026 -- Plus Therapeutics, a healthcare company focused on precision diagnostics and radiopharmaceuticals for central nervous system cancers, reported its financial results for the...